EFFECTS OF PHYSICAL ACTIVITY AND EXERCISE INTERVENTIONS ON TREATMENT-RELATED SIDE EFFECTS IN CHILDREN DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A REVIEW

Abstract

Acute lymphoblastic leukemia (ALL) is the most common type of cancer in childhood. Today, thanks to advancements in diagnosis and treatment, the survival rate has significantly improved. However, treatment-related side effects negatively affect the quality of life in both the short and long term. Physical activity and exercise interventions are useful in eliminating these side effects. In this review, the role and characteristics of physical activity and exercise in children diagnosed with ALL, were examined. Studies have revealed that it is beneficial to increase the number of steps or the activity that children enjoy in physical activity interventions. The content of exercise programs is created according to the patient's needs or targeted achievement. Generally, aerobic, strengthening, stretching, plyometric and game-based exercises were used. Findings demonstrate that physical activity and exercise have beneficial effects on fatigue, sleep quality, cardiorespiratory fitness, muscle strength, joint range of motion, functional mobility, bone health and body weight.

Keywords

• Exercise therapy
• leukemia
• chemotherapy

AKUT LENFOBLASTİK LÖSEMİ TANILI ÇOCUKLARDA FİZİKSEL AKTİVİTE VE EGZERSİZ UYGULAMALARININ TEDAVİ İLE İLİŞKİLİ YAN ETKİLER ÜZERİNE ETKİLERİ: DERLEME

Öz

Akut lenfoblastik lösemi (ALL) çocukluk çağında en sık görülen kanser türüdür. Günümüzde tanı ve tedavisindeki gelişmeler sayesinde sağ kalım oranı önemli ölçüde artmıştır, ancak kısa ve uzun dönemde tedavi ile ilişkili yan etkiler yaşam kalitesini olumsuz yönde etkilemektedir. Fiziksel aktivite ve egzersiz uygulamaları bu yan etkilerin giderilmesinde yararlı olmaktadır. Bu derlemede ALL tanılı çocuklarda fiziksel aktivite ve egzersizin rolü ve özellikleri incelenmiştir. Araştırmalar fiziksel aktivite uygulamalarında adım sayısının veya çocukların keyif aldıkları aktivitelerin artırılmasının yararlı olduğunu ortaya koymuştur. Egzersiz programlarının içeriği ise hastanın ihtiyacı veya hedeflenen kazanıma göre oluşturulmuştur. Genellikle aerobik, kuvvetlendirme, germe, pliometrik ve oyun temelli egzersizlerden yararlanılmıştır. Bulgular fiziksel aktivite ve egzersizin yorgunluk, uyku kalitesi, kardiyorespiratuar uygunluk, kas kuvveti, eklem hareket açıklığı, fonksiyonel mobilite, kemik sağlığı ve vücut ağırlığı üzerine yararlı etkileri olduğunu göstermektedir.

Anahtar Kelimeler

• Egzersiz tedavisi
• lösemi
• kemoterapi

Kaynakça

1. 1. Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M et al. Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2020;18(1):81-112.
2. 2. PDQ Pediatric Treatment Editorial Board. Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®): Health Professional Version. 2024 In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US). Available at: https://www.ncbi.nlm.nih.gov/books/NBK65763/ Accessed on May 5, 2024.
3. 3. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2012; 30(4):1663–1669
4. 4. Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015; 62:61–73.
5. 5. Seibel NL. Treatment of Acute Lymphoblastic Leukemia in Children and Adolescents: Peaks and Pitfalls. Hematology Am Soc Hematol Educ Program 2008; 2008 (1): 374–380.
6. 6. Mehta PA, Davies SM. Allogeneic transplantation for childhood ALL. Bone Marrow Transplantation. 2008; 41(2):133-139.
7. 7. Lan X, Wu J, Liao Z, Wu Y, Hu R. Prevalence of symptoms in children with acute lymphoblastic leukaemia: a systematic review and meta-analysis. BMC Cancer. 2023; 23(1):1113.
8. 8. Yeh CH, Chiang YC, Lin L, Yang CP, Chien LC, Weaver MA et al. Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy. British Journal of Cancer. 2008; 99(1)23-29.

9. 9. Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer. 2003;97:2898–2903.
10. 10. Chow EJ, Pihoker C, Friedman DL, Lee SJ, McCune JS, Wharton C, et al. Glucocorticoids and Insulin Resistance in Children With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2013; 60:621–626.
11. 11. Kamdem LK, Hamilton L, Cheng C, Liu W, Yang W, Johnson JA, et al. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2008; 18:507–514.
12. 12. Lowas SR, Marks D, Malempati S. Prevalence of Transient Hyperglycemia During Induction Chemotherapy for Pediatric Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2009; 52:814–818.
13. 13. Velentza L, Zaman F, Sävendahl L. Bone health in glucocorticoid-treated childhood acute lymphoblastic leukemia. Critical Reviews in Oncology/Hematology. 2021; 168:103492.
14. 14. Kunstreich M, Kummer S, Laws HJ, Borkhardt A, Kuhlen M. Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 2016; 101(11):1295.
15. 15. Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK., Johnston K, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood, The Journal of the American Society of Hematology, 2003; 101(10):3809-3817.
16. 16. Guis S, Mattéi JP, Lioté F. Drug-induced and toxic myopathies. Best Practice & Research Clinical Rheumatology. 2003; 17(6):877-907.
17. 17. Waber DP, Carpentieri SC, Klar N, Silverman LB, Schwenn M, Hurwitz CA, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. Journal of Pediatric Hematology/Oncology. 2000; 22(3): 206-213.
18. 18. Pound CM, Clark C, Ni A, Athale U, Lewis V, Halton JM. Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial. Journal of Pediatric Hematology/Oncology. 2012; 34(7): 517-523.
19. 19. Mrakotsky CM, Silverman LB, Dahlberg SE, Alyman MCA, Sands SA, Queally JT et al. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age‐dependent: report from Dana‐Farber Cancer Institute ALL Consortium Protocol 00‐01. Pediatric Blood & Cancer. 2011; 57(3):492-498.
20. 20. Toopchizadeh V, Barzegar M, Rezamand A, Feiz AH. Electrophysiological consequences of vincristine contained chemotherapy in children: a cohort study. Journal of Pediatric Neurology. 2009; 7(4):351-356.
21. 21. Gomber S, Dewan P, Chhonker D. Vincristine induced neurotoxicity in cancer patients. The Indian Journal of Pediatrics. 2010; 77:97-100.
22. 22. Lavoie Smith EM, Li L, Chiang CW, Thomas K, Hutchinson RJ, Wells EM et al. Patterns and severity of vincristine‐induced peripheral neuropathy in children with acute lymphoblastic leukemia. Journal of the Peripheral Nervous System. 2015; 20(1):37-46.
23. 23. Simbre VC, Duffy SA, Dadlani GH, Miller TL, Lipshultz SE. Cardiotoxicity of cancer chemotherapy: implications for children. Paediatr Drugs 2005;7:187–202.
24. 24. Christiansen JR, Kanellopoulos A, Lund MB, Massey R, Dalen H, Kiserud CE et al. Impaired exercise capacity and left ventricular function in long‐term adult survivors of childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2015; 62(8):1437-1443.
25. 25. Hartman A, Hop W, Takken T, Pieters R, van den Heuvel‐Eibrink M. Motor performance and functional exercise capacity in survivors of pediatric acute lymphoblastic leukemia. Pediatric blood & Cancer, 2013; 60(3):494-499.
26. 26. Yeh CH, Man Wai JP, Lin US, Chiang YC. A pilot study to examine the feasibility and effects of a home-based aerobic program on reducing fatigue in children with acute lymphoblastic leukemia. Cancer Nursing. 2011;34(1):3–12.
27. 27. Hooke MC, Gilchrist L, Tanner L, Hart N, Withycombe JS. Use of a Fitness Tracker to Promote Physical Activity in Children With Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2016;63(4):684–689.
28. 28. Abd El Baky AM, Elhakk SMA. Impact of aerobic exercise on physical fitness and fatigue in children with acute lymphoblastic leukemia. International Journal of Therapies and Rehabilitation Research. 2017; 6(2):137.
29. 29. Masoud AE, Shaheen AAM, Algabbani MF, AlEisa E, AlKofide, A. Effectiveness of exergaming in reducing cancer-related fatigue among children with acute lymphoblastic leukemia: a randomized controlled trial. Annals of Medicine. 2023; 55(1):2224048.
30. 30. Tanriverdi M, Cakir E, Akkoyunlu ME, Cakir FB. Effect of virtual reality-based exercise intervention on sleep quality in children with acute lymphoblastic leukemia and healthy siblings: A randomized controlled trial. Palliative & Supportive Care. 2022; 20(4):455-461.
31. 31. Moyer-Mileur LJ, Ransdell L, Bruggers CS. Fitness of children with standard-risk acute lymphoblastic leukemia during maintenance therapy: response to a home-based exercise and nutrition program. Journal of Pediatric Hematology/Oncology. 2009; 31(4):259-266.
32. 32. San Juan AF, Fleck SJ, Chamorro-Vina C, Mate-Munoz JL, Moral S, Perez M, et al. Effects of an intrahospital exercise program intervention for children with leukemia. Medicine & Science in Sports & Exercise. 2007; 39(1):13-21.
33. 33. Manchola-González JD, Bagur-Calafat C, Girabent-Farrés M, Serra-Grima JR, Pérez, RÁ, Garnacho-Castaño MV, et al. Effects of a home-exercise programme in childhood survivors of acute lymphoblastic leukaemia on physical fitness and physical functioning: results of a randomised clinical trial. Support Care Cancer. 2020; 28:3171-3178.
34. 34. Marchese VG, Chiarello LA, Lange BJ. Effects of physical therapy intervention for children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2004; 42(2): 127-133.
35. 35. Takken T, van der Torre P, Zwerink M, Hulzebos EH, Bierings M, Helders PJ, et al. Development, feasibility and efficacy of a community‐based exercise training program in pediatric cancer survivors. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2009; 18(4):440-448.
36. 36. Perondi MB, Gualano B, Artioli GG, de Salles Painelli V, Odone Filho V, Netto G, et al. Effects of a combined aerobic and strength training program in youth patients with acute lymphoblastic leukemia. Journal of Sports Science & Medicine. 2012;11(3):387-392.
37. 37. Wright MJ, Collins L, Christie A, Birken K, Dettmer E, Nathan PC. A comprehensive healthy lifestyle program for children receiving treatment for acute lymphoblastic leukemia: feasibility and preliminary efficacy data. Rehabilitation Oncology. 2013; 31(3):6-13.
38. 38. Tanir MK, Kuguoglu S. Impact of Exercise on Lower Activity Levels in Children with Acute Lymphoblastic Leukemia: A Randomized Controlled Trial from Turkey. Rehabilitation Nursing. 2013; 38(1):48–59.
39. 39. Tanner LR, Hooke MC (2019). Improving body function and minimizing activity limitations in pediatric leukemia survivors: The lasting impact of the Stoplight Program. Pediatric Blood & Cancer, 2019; 66(5): e27596.
40. 40. Hartman A, te Winkel ML, van Beek RD, de Muinck Keizer‐Schrama SMPF, Kemper, HCG, Hop WCJ, et al. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2009; 53(1):64-71.
41. 41. Waked I, Albenasy K. Bone mineral density, lean body mass and bone biomarkers following physical exercise in children with acute lymphoblastic leukemia undergoing chemotherapy. Iranian Journal of Blood and Cancer. 2018; 10(3):69-75.
42. 42. Cox CL, Zhu L, Kaste SC, Srivastava K, Barnes L, Nathan, PC, et al. Modifying bone mineral density, physical function, and quality of life in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2018; 65(4):e26929.
43. 43. Lambert G, Alos N, Bernier P, Laverdière C, Kairy D, Drummond K, et al. Home-based Telehealth exercise intervention in early-on survivors of childhood acute lymphoblastic leukemia: Feasibility study. JMIR Cancer. 2021; 7(2): e25569.
44. 44. Elnaggar RK, Mohamed RR. Aqua-plyometric exercises: potential implications for bone mineral density, functional capacity, and quality of life in survivors of childhood acute lymphoblastic leukemia. Seminars in Oncology Nursing. 2021; 37(6):151225.
45. 45. Huang JS, Dillon L, Terrones L, Schubert L, Roberts W, Finklestein J, et al. Fit4Life: a weight loss intervention for children who have survived childhood leukemia. Pediatric Blood & Cancer. 2014; 61(5):894-900.
46. 46. Zhang FF, Kelly M, Du M, Welch JJ, Santacruz N, Rhoades J, et al. Early lifestyle intervention for obesity prevention in pediatric survivors of acute lymphoblastic leukemia. Nutrients. 2019;11(11):2631.